醫學寫作人工智慧市場規模、佔有率、趨勢分析報告：按類型、最終用途、地區、細分預測，2025-2030 年

AI In Medical Writing Market Size, Share, & Trends Analysis Report By Type (Clinical Writing, Type Writing), By End-use (Medical Devices, Pharmaceutical), By Region, And Segment Forecasts, 2025 - 2030

出版日期: 2025年01月15日 | 出版商:

Grand View Research | 英文 100 Pages | 商品交期: 2-10個工作天內

價格

簡介目錄圖表

醫學寫作人工智慧市場的成長和趨勢

根據Grand View Research, Inc.的最新報告，全球醫學寫作人工智慧市場規模預計到2030年將達到17.6002億美元，2025年至2030年期間的複合年成長率為12.52%。

推動市場擴張的一個主要因素是醫療保健產業對人工智慧（AI）等機器學習的接受度日益提高。此外，降低醫療保健成本的需求不斷成長以及製藥公司為降低成本而增加研發投資也在推動市場成長。新冠肺炎疫情對市場的影響正逐漸顯現。疫情導致研發活動和臨床試驗停頓。

此外，預算限制導致許多製藥公司削減投資。在疫情初期，醫學日誌的投稿量也有所下降，對市場成長產生了負面影響。然而，在 COVID-19 疫情期間，企業、研究團體和政府機構在開發創新治療方法方面的合作努力的價值已經得到證實。因此，醫療設備、生物技術和生命科學公司打算增加對醫學作家的投資。因此，在 COVID-19 疫情期間，醫療保健產業對 AI 的需求正在增加。

醫學寫作人工智慧市場報告重點

由於需要向當局提交監管文件，打字部分佔據市場主導地位，佔 2024 年總收入的 32.89%。這導致該領域對醫學寫作人工智慧的需求增加。
根據最終用途，製藥業佔據市場主導地位，2024 年的收益佔有率為 33.33%。
這一高佔有率歸因於對新藥和新治療方法研發活動的大量投資，從而推動了這一終端使用領域對醫學寫作人工智慧的需求。
2024 年，北美將以 30.12% 的收益佔有率佔據市場主導地位。這是由於技術不斷進步、醫療基礎設施不斷增加以及藥物臨床測試和核准的數量不斷增加。

2024 年及 2030 年區域市場佔有率分析
區域市場儀表板
全球區域市場概況
2018-2030 年市場規模及預測趨勢分析
北美洲
- 美國
- 加拿大
- 墨西哥
歐洲
- 英國
- 德國
- 法國
- 義大利
- 西班牙
- 挪威
- 瑞典
- 丹麥
亞太地區
- 日本
- 中國
- 印度
- 澳洲
- 韓國
- 泰國
拉丁美洲
- 巴西
- 阿根廷
中東和非洲
- 南非
- 沙烏地阿拉伯
- 阿拉伯聯合大公國
- 科威特

第7章競爭格局

主要市場參與企業的近期趨勢和影響分析
公司/競爭對手分類
2024 年主要企業的市場佔有率/地位分析
公司簡介
- Parexel International（MA）Corporation
- Trilogy Writing &Consulting GmbH
- Freyr
- Cactus Communications
- GENINVO
- IQVIA Inc.
- ICON plc
- Syneos Health
- IBM
- Teladoc Health, Inc.
- SmarterDx
- Abridge Al, Inc.
- Suki AI, Inc.
- Movano
- Heidi
- Corti
- Tortus AI.
- Nabla Technologies

簡介目錄圖表

Product Code: GVR-4-68040-097-9

AI In Medical Writing Market Growth & Trends:

The global AI in medical writing market size is anticipated to reach USD 1,760.02 million by 2030, registering a CAGR of 12.52% from 2025 to 2030, according to a new report by Grand View Research, Inc. The primary factor driving the market expansion is the growing acceptance of machine learning, such as Artificial Intelligence(AI), in the healthcare industry. Moreover, the rising demand for reducing healthcare expenditures and increasing R&D investments by pharmaceutical companies to reduce expenses are other factors that are propelling market growth. The COVID-19 pandemic had affected the market moderately. The pandemic caused a pause in research and development activities as well as clinical trials.

Moreover, budgetary limitations led many pharmaceutical companies to reduce their investments. The initial stages of the pandemic also resulted in a decrease in submissions to healthcare journals, negatively impacting market growth. However, the significance of collaborative efforts between companies, research groups, and government bodies in the development of innovative therapies was demonstrated during the COVID-19 pandemic. Consequently, medical device, biotechnology, and life science companies have intentions to boost their investment in medical writers. Thus, increasing the demand for AI in the healthcare industry during the COVID-19 pandemic.

AI In Medical Writing Market Report Highlights:

Based on type, the typewriting segment dominated the market with a share of 32.89% of the overall revenue in 2024 due to the necessity of submitting regulatory documents to the authorities. Thus, boosting the demand for AI in medical writing in this segment
Based on end-use, the pharmaceutical segment dominated the market with a revenue share of 33.33% in 2024.
The high share was attributed to the heavy investments in R&D activities to develop new drugs and treatments, which augmented the demand for AI in medical writing in this end-use segment
In 2024, North America dominated the market with a revenue share of 30.12% owing to the continuous technological advancements, increasing healthcare infrastructure, and a high number of drug trials & their approvals

Chapter 1. Research Methodology and Scope

1.1. Market Segmentation & Scope
- 1.1.1. Type
- 1.1.2. End Use
- 1.1.3. Regional scope
- 1.1.4. Estimates and forecast timeline.
1.2. Research Methodology
1.3. Information Procurement
- 1.3.1. Purchased database.
- 1.3.2. GVR's internal database
- 1.3.3. Secondary sources
- 1.3.4. Primary research
- 1.3.5. Details of primary research
1.4. Information or Data Analysis
- 1.4.1. Data analysis models
1.5. Market Formulation & Validation
1.6. Model Details
- 1.6.1. Commodity flow analysis (Model 1)
- 1.6.2. Approach 1: Commodity flow approach
1.7. List of Secondary Sources
1.8. List of Primary Sources
1.9. Objectives

Chapter 2. Executive Summary

2.1. Market Outlook
2.2. Segment Outlook
- 2.2.1. Type outlook
- 2.2.2. End use outlook
- 2.2.3. Regional outlook
2.3. Competitive Insights

Chapter 3. AI in Medical Writing Market Variables, Trends & Scope

3.1. Market Dynamics
- 3.1.1. Market driver analysis
- 3.1.2. Market restraint analysis
- 3.1.3. Market Opportunities
3.2. AI in Medical Writing Market Analysis Tools
- 3.2.1. Industry Analysis - Porter's
  - 3.2.1.1. Supplier power
  - 3.2.1.2. Buyer power
  - 3.2.1.3. Substitution threat
  - 3.2.1.4. Threat of new entrant
  - 3.2.1.5. Competitive rivalry
- 3.2.2. PESTEL Analysis
  - 3.2.2.1. Political landscape
  - 3.2.2.2. Economic landscape
  - 3.2.2.3. Social landscape
  - 3.2.2.4. Technological landscape
  - 3.2.2.5. Environmental landscape
  - 3.2.2.6. Legal landscape
- 3.2.3. COVID-19 Impact Analysis
- 3.2.4. Case Studies

Chapter 4. AI in Medical Writing Market: Type Estimates & Trend Analysis

4.1. Type Market Share, 2024 & 2030
4.2. Segment Dashboard
4.3. Global AI in Medical Writing Market by Product Type Outlook
4.4. Clinical Writing
- 4.4.1. Market estimates and forecast 2018 to 2030 (USD Million)
4.5. Scientific Writing
- 4.5.1. Market estimates and forecast 2018 to 2030 (USD Million)
4.6. Type Writing
- 4.6.1. Market estimates and forecast 2018 to 2030 (USD Million)
4.7. Others
- 4.7.1. Market estimates and forecast 2018 to 2030 (USD Million)

Chapter 5. AI in Medical Writing Market: End Use Estimates & Trend Analysis

5.1. End Use Market Share, 2024 & 2030
5.2. Segment Dashboard
5.3. Global AI in Medical Writing Market by End Use Outlook
5.4. Medical Devices
- 5.4.1. Market estimates and forecast 2018 to 2030 (USD Million)
5.5. Pharmaceutical
- 5.5.1. Market estimates and forecast 2018 to 2030 (USD Million)
5.6. Biotechnology
- 5.6.1. Market estimates and forecast 2018 to 2030 (USD Million)
5.7. Others
- 5.7.1. Market estimates and forecast 2018 to 2030 (USD Million)

Chapter 6. AI in Medical Writing Market: Regional Estimates & Trend Analysis, By Product, By Type, By End Use

6.1. Regional Market Share Analysis, 2024 & 2030
6.2. Regional Market Dashboard
6.3. Global Regional Market Snapshot
6.4. Market Size & Forecasts Trend Analysis, 2018 to 2030:
6.5. North America
- 6.5.1. U.S.
  - 6.5.1.1. Key country dynamics
  - 6.5.1.2. Regulatory framework/ reimbursement structure
  - 6.5.1.3. Competitive scenario
  - 6.5.1.4. U.S. market estimates and forecasts 2018 to 2030 (USD Million)
- 6.5.2. Canada
  - 6.5.2.1. Key country dynamics
  - 6.5.2.2. Regulatory framework/ reimbursement structure
  - 6.5.2.3. Competitive scenario
  - 6.5.2.4. Canada market estimates and forecasts 2018 to 2030 (USD Million)
- 6.5.3. Mexico
  - 6.5.3.1. Key country dynamics
  - 6.5.3.2. Regulatory framework/ reimbursement structure
  - 6.5.3.3. Competitive scenario
  - 6.5.3.4. Canada market estimates and forecasts 2018 to 2030 (USD Million)
6.6. Europe
- 6.6.1. UK
  - 6.6.1.1. Key country dynamics
  - 6.6.1.2. Regulatory framework/ reimbursement structure
  - 6.6.1.3. Competitive scenario
  - 6.6.1.4. UK market estimates and forecasts 2018 to 2030 (USD Million)
- 6.6.2. Germany
  - 6.6.2.1. Key country dynamics
  - 6.6.2.2. Regulatory framework/ reimbursement structure
  - 6.6.2.3. Competitive scenario
  - 6.6.2.4. Germany market estimates and forecasts 2018 to 2030 (USD Million)
- 6.6.3. France
  - 6.6.3.1. Key country dynamics
  - 6.6.3.2. Regulatory framework/ reimbursement structure
  - 6.6.3.3. Competitive scenario
  - 6.6.3.4. France market estimates and forecasts 2018 to 2030 (USD Million)
- 6.6.4. Italy
  - 6.6.4.1. Key country dynamics
  - 6.6.4.2. Regulatory framework/ reimbursement structure
  - 6.6.4.3. Competitive scenario
  - 6.6.4.4. Italy market estimates and forecasts 2018 to 2030 (USD Million)
- 6.6.5. Spain
  - 6.6.5.1. Key country dynamics
  - 6.6.5.2. Regulatory framework/ reimbursement structure
  - 6.6.5.3. Competitive scenario
  - 6.6.5.4. Spain market estimates and forecasts 2018 to 2030 (USD Million)
- 6.6.6. Norway
  - 6.6.6.1. Key country dynamics
  - 6.6.6.2. Regulatory framework/ reimbursement structure
  - 6.6.6.3. Competitive scenario
  - 6.6.6.4. Norway market estimates and forecasts 2018 to 2030 (USD Million)
- 6.6.7. Sweden
  - 6.6.7.1. Key country dynamics
  - 6.6.7.2. Regulatory framework/ reimbursement structure
  - 6.6.7.3. Competitive scenario
  - 6.6.7.4. Sweden market estimates and forecasts 2018 to 2030 (USD Million)
- 6.6.8. Denmark
  - 6.6.8.1. Key country dynamics
  - 6.6.8.2. Regulatory framework/ reimbursement structure
  - 6.6.8.3. Competitive scenario
  - 6.6.8.4. Denmark market estimates and forecasts 2018 to 2030 (USD Million)
6.7. Asia Pacific
- 6.7.1. Japan
  - 6.7.1.1. Key country dynamics
  - 6.7.1.2. Regulatory framework/ reimbursement structure
  - 6.7.1.3. Competitive scenario
  - 6.7.1.4. Japan market estimates and forecasts 2018 to 2030 (USD Million)
- 6.7.2. China
  - 6.7.2.1. Key country dynamics
  - 6.7.2.2. Regulatory framework/ reimbursement structure
  - 6.7.2.3. Competitive scenario
  - 6.7.2.4. China market estimates and forecasts 2018 to 2030 (USD Million)
- 6.7.3. India
  - 6.7.3.1. Key country dynamics
  - 6.7.3.2. Regulatory framework/ reimbursement structure
  - 6.7.3.3. Competitive scenario
  - 6.7.3.4. India market estimates and forecasts 2018 to 2030 (USD Million)
- 6.7.4. Australia
  - 6.7.4.1. Key country dynamics
  - 6.7.4.2. Regulatory framework/ reimbursement structure
  - 6.7.4.3. Competitive scenario
  - 6.7.4.4. Australia market estimates and forecasts 2018 to 2030 (USD Million)
- 6.7.5. South Korea
  - 6.7.5.1. Key country dynamics
  - 6.7.5.2. Regulatory framework/ reimbursement structure
  - 6.7.5.3. Competitive scenario
  - 6.7.5.4. South Korea market estimates and forecasts 2018 to 2030 (USD Million)
- 6.7.6. Thailand
  - 6.7.6.1. Key country dynamics
  - 6.7.6.2. Regulatory framework/ reimbursement structure
  - 6.7.6.3. Competitive scenario
  - 6.7.6.4. Singapore market estimates and forecasts 2018 to 2030 (USD Million)
6.8. Latin America
- 6.8.1. Brazil
  - 6.8.1.1. Key country dynamics
  - 6.8.1.2. Regulatory framework/ reimbursement structure
  - 6.8.1.3. Competitive scenario
  - 6.8.1.4. Brazil market estimates and forecasts 2018 to 2030 (USD Million)
- 6.8.2. Argentina
  - 6.8.2.1. Key country dynamics
  - 6.8.2.2. Regulatory framework/ reimbursement structure
  - 6.8.2.3. Competitive scenario
  - 6.8.2.4. Argentina market estimates and forecasts 2018 to 2030 (USD Million)
6.9. MEA
- 6.9.1. South Africa
  - 6.9.1.1. Key country dynamics
  - 6.9.1.2. Regulatory framework/ reimbursement structure
  - 6.9.1.3. Competitive scenario
  - 6.9.1.4. South Africa market estimates and forecasts 2018 to 2030 (USD Million)
- 6.9.2. Saudi Arabia
  - 6.9.2.1. Key country dynamics
  - 6.9.2.2. Regulatory framework/ reimbursement structure
  - 6.9.2.3. Competitive scenario
  - 6.9.2.4. Saudi Arabia market estimates and forecasts 2018 to 2030 (USD Million)
- 6.9.3. UAE
  - 6.9.3.1. Key country dynamics
  - 6.9.3.2. Regulatory framework/ reimbursement structure
  - 6.9.3.3. Competitive scenario
  - 6.9.3.4. UAE market estimates and forecasts 2018 to 2030 (USD Million)
- 6.9.4. Kuwait
  - 6.9.4.1. Key country dynamics
  - 6.9.4.2. Regulatory framework/ reimbursement structure
  - 6.9.4.3. Competitive scenario
  - 6.9.4.4. Kuwait market estimates and forecasts 2018 to 2030 (USD Million)

Chapter 7. Competitive Landscape

7.1. Recent Developments & Impact Analysis, By Key Market Participants
7.2. Company/Competition Categorization
7.3. Key company market share/position analysis, 2024
7.4. Company Profiles
- 7.4.1. Parexel International (MA) Corporation.
  - 7.4.1.1. Company overview
  - 7.4.1.2. Financial performance
  - 7.4.1.3. Technology Type benchmarking
  - 7.4.1.4. Strategic initiatives
- 7.4.2. Trilogy Writing & Consulting GmbH
  - 7.4.2.1. Company overview
  - 7.4.2.2. Financial performance
  - 7.4.2.3. Technology Type benchmarking
  - 7.4.2.4. Strategic initiatives
- 7.4.3. Freyr
  - 7.4.3.1. Company overview
  - 7.4.3.2. Financial performance
  - 7.4.3.3. Technology Type benchmarking
  - 7.4.3.4. Strategic initiatives
- 7.4.4. Cactus Communications
  - 7.4.4.1. Company overview
  - 7.4.4.2. Financial performance
  - 7.4.4.3. Technology Type benchmarking
  - 7.4.4.4. Strategic initiatives
- 7.4.5. GENINVO
  - 7.4.5.1. Company overview
  - 7.4.5.2. Financial performance
  - 7.4.5.3. Technology Type benchmarking
  - 7.4.5.4. Strategic initiatives
- 7.4.6. IQVIA Inc.
  - 7.4.6.1. Company overview
  - 7.4.6.2. Financial performance
  - 7.4.6.3. Technology Type benchmarking
  - 7.4.6.4. Strategic initiatives
- 7.4.7. ICON plc
  - 7.4.7.1. Company overview
  - 7.4.7.2. Financial performance
  - 7.4.7.3. Technology Type benchmarking
  - 7.4.7.4. Strategic initiatives
- 7.4.8. Syneos Health
  - 7.4.8.1. Company overview
  - 7.4.8.2. Financial performance
  - 7.4.8.3. Technology Type benchmarking
  - 7.4.8.4. Strategic initiatives
- 7.4.9. IBM
  - 7.4.9.1. Company overview
  - 7.4.9.2. Financial performance
  - 7.4.9.3. Technology Type benchmarking
  - 7.4.9.4. Strategic initiatives
- 7.4.10. Teladoc Health, Inc.
  - 7.4.10.1. Company overview
  - 7.4.10.2. Financial performance
  - 7.4.10.3. Technology Type benchmarking
  - 7.4.10.4. Strategic initiatives
- 7.4.11. SmarterDx
  - 7.4.11.1. Company overview
  - 7.4.11.2. Financial performance
  - 7.4.11.3. Technology Type benchmarking
  - 7.4.11.4. Strategic initiatives
- 7.4.12. Abridge Al, Inc.
  - 7.4.12.1. Company overview
  - 7.4.12.2. Financial performance
  - 7.4.12.3. Technology Type benchmarking
  - 7.4.12.4. Strategic initiatives
- 7.4.13. Suki AI, Inc.
  - 7.4.13.1. Company overview
  - 7.4.13.2. Financial performance
  - 7.4.13.3. Technology Type benchmarking
  - 7.4.13.4. Strategic initiatives
- 7.4.14. Movano
  - 7.4.14.1. Company overview
  - 7.4.14.2. Financial performance
  - 7.4.14.3. Technology Type benchmarking
  - 7.4.14.4. Strategic initiatives
- 7.4.15. Heidi
  - 7.4.15.1. Company overview
  - 7.4.15.2. Financial performance
  - 7.4.15.3. Technology Type benchmarking
  - 7.4.15.4. Strategic initiatives
- 7.4.16. Corti
  - 7.4.16.1. Company overview
  - 7.4.16.2. Financial performance
  - 7.4.16.3. Technology Type benchmarking
  - 7.4.16.4. Strategic initiatives
- 7.4.17. Tortus AI.
  - 7.4.17.1. Company overview
  - 7.4.17.2. Financial performance
  - 7.4.17.3. Technology Type benchmarking
  - 7.4.17.4. Strategic initiatives
- 7.4.18. Nabla Technologies
  - 7.4.18.1. Company overview
  - 7.4.18.2. Financial performance
  - 7.4.18.3. Technology Type benchmarking
  - 7.4.18.4. Strategic initiatives

簡介目錄圖表

List of Tables

Table 1 List of secondary sources
Table 2 List of abbreviations
Table 3 North America AI in medical writing market estimates and forecasts by type, 2018 - 2030 (USD Million)
Table 4 North America AI in medical writing market estimates and forecasts by end use, 2018 - 2030 (USD Million)
Table 5 U.S. AI in medical writing market estimates and forecasts by type, 2018 - 2030 (USD Million)
Table 6 U.S. AI in medical writing market estimates and forecasts by end use, 2018 - 2030 (USD Million)
Table 7 Canada AI in medical writing market estimates and forecasts by type, 2018 - 2030 (USD Million)
Table 8 Canada AI in medical writing market estimates and forecasts by end use, 2018 - 2030 (USD Million)
Table 9 Mexico AI in medical writing market estimates and forecasts by type, 2018 - 2030 (USD Million)
Table 10 Mexico AI in medical writing market estimates and forecasts by end use, 2018 - 2030 (USD Million)
Table 11 Europe AI in medical writing market estimates and forecasts by type, 2018 - 2030 (USD Million)
Table 12 Europe AI in medical writing market estimates and forecasts by end use, 2018 - 2030 (USD Million)
Table 13 UK AI in medical writing market estimates and forecasts by type, 2018 - 2030 (USD Million)
Table 14 UK AI in medical writing market estimates and forecasts by end use, 2018 - 2030 (USD Million)
Table 15 Germany AI in medical writing market estimates and forecasts by type, 2018 - 2030 (USD Million)
Table 16 Germany AI in medical writing market estimates and forecasts by end use, 2018 - 2030 (USD Million)
Table 17 France AI in medical writing market estimates and forecasts by type, 2018 - 2030 (USD Million)
Table 18 France AI in medical writing market estimates and forecasts by end use, 2018 - 2030 (USD Million)
Table 19 Italy AI in medical writing market estimates and forecasts by type, 2018 - 2030 (USD Million)
Table 20 Italy AI in medical writing market estimates and forecasts by end use, 2018 - 2030 (USD Million)
Table 21 Spain AI in medical writing market estimates and forecasts by type, 2018 - 2030 (USD Million)
Table 22 Spain AI in medical writing market estimates and forecasts by end use, 2018 - 2030 (USD Million)
Table 23 Denmark AI in medical writing market estimates and forecasts by type, 2018 - 2030 (USD Million)
Table 24 Denmark AI in medical writing market estimates and forecasts by end use, 2018 - 2030 (USD Million)
Table 25 Sweden AI in medical writing market estimates and forecasts by type, 2018 - 2030 (USD Million)
Table 26 Sweden AI in medical writing market estimates and forecasts by end use, 2018 - 2030 (USD Million)
Table 27 Norway AI in medical writing market estimates and forecasts by type, 2018 - 2030 (USD Million)
Table 28 Norway AI in medical writing market estimates and forecasts by end use, 2018 - 2030 (USD Million)
Table 29 Asia Pacific AI in medical writing market estimates and forecasts by type, 2018 - 2030 (USD Million)
Table 30 Asia Pacific AI in medical writing market estimates and forecasts by end use, 2018 - 2030 (USD Million)
Table 31 Japan AI in medical writing market estimates and forecasts by type, 2018 - 2030 (USD Million)
Table 32 Japan AI in medical writing market estimates and forecasts by end use, 2018 - 2030 (USD Million)
Table 33 China AI in medical writing market estimates and forecasts by type, 2018 - 2030 (USD Million)
Table 34 China AI in medical writing market estimates and forecasts by end use, 2018 - 2030 (USD Million)
Table 35 India AI in medical writing market estimates and forecasts by type, 2018 - 2030 (USD Million)
Table 36 India AI in medical writing market estimates and forecasts by end use, 2018 - 2030 (USD Million)
Table 37 Australia AI in medical writing market estimates and forecasts by type, 2018 - 2030 (USD Million)
Table 38 Australia AI in medical writing market estimates and forecasts by end use, 2018 - 2030 (USD Million)
Table 39 South Korea AI in medical writing market estimates and forecasts by type, 2018 - 2030 (USD Million)
Table 40 South Korea AI in medical writing market estimates and forecasts by end use, 2018 - 2030 (USD Million)
Table 41 Thailand AI in medical writing market estimates and forecasts by type, 2018 - 2030 (USD Million)
Table 42 Thailand AI in medical writing market estimates and forecasts by end use, 2018 - 2030 (USD Million)
Table 43 Latin America AI in medical writing market estimates and forecasts by type, 2018 - 2030 (USD Million)
Table 44 Latin America AI in medical writing market estimates and forecasts by end use, 2018 - 2030 (USD Million)
Table 45 Brazil AI in medical writing market estimates and forecasts by type, 2018 - 2030 (USD Million)
Table 46 Brazil AI in medical writing market estimates and forecasts by end use, 2018 - 2030 (USD Million)
Table 47 Argentina AI in medical writing market estimates and forecasts by type, 2018 - 2030 (USD Million)
Table 48 Argentina AI in medical writing market estimates and forecasts by end use, 2018 - 2030 (USD Million)
Table 49 MEA AI in medical writing market estimates and forecasts by type, 2018 - 2030 (USD Million)
Table 50 MEA AI in medical writing market estimates and forecasts by end use, 2018 - 2030 (USD Million)
Table 51 South Africa AI in medical writing market estimates and forecasts by type, 2018 - 2030 (USD Million)
Table 52 South Africa AI in medical writing market estimates and forecasts by end use, 2018 - 2030 (USD Million)
Table 53 Saudi Arabia AI in medical writing market estimates and forecasts by type, 2018 - 2030 (USD Million)
Table 54 Saudi Arabia AI in medical writing market estimates and forecasts by end use, 2018 - 2030 (USD Million)
Table 55 UAE AI in medical writing market estimates and forecasts by type, 2018 - 2030 (USD Million)
Table 56 UAE AI in medical writing market estimates and forecasts by end use, 2018 - 2030 (USD Million)
Table 57 Kuwait AI in medical writing market estimates and forecasts by type, 2018 - 2030 (USD Million)
Table 58 Kuwait AI in medical writing market estimates and forecasts by end use, 2018 - 2030 (USD Million)